Catch up on our latest Webinar: Preparing Self-Funded Plans for the Game-Changing Impact of Biosimilars
Featuring PCM’s Chief Pharmacist, Dr. David Merritt PharmD, RPh, who takes a closer look at how biosimilar adoption will affect plan and patient costs, breaking down spend on an actual group and discussing ways to increase adoption through physician and patient education. Watch Now.
INDUSTRY NEWS
- Why is insurance more expensive than cash prices?
- Potential for biosimilars to lower cost of diabetes medication.
- New technology likely to change drug discount management.
- Voluntary recall of Vancomycin Hydrochloride for Oral Solution.
- Voluntary recall of Methocarbomal Injection.
- Voluntary recall of Atovaquone Oral Suspension.
- Voluntary Recall of Honeywell Fendall product.